This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A third look: Discussing the standard of care and the potential of Exparel (bupivacaine liposome injectible suspension) from Pacira in treating post-operative pain internationally
Ticker(s): PCRXWho's the expert?
- Critical Care physician and Anesthesia Emergency Doctor in medicine
- Field of research are in Mechanical Ventilation, Antibiotics guidelines, Infection diseases, Heart Failure and Lung failure monitoring invasive and Non invasive monitoring, Pain therapy services and therapy.
- Advanced Technologist in Medicine, Medical Malpractice and litigation Advisor, Telehealth, and Medical education and training for junior doctors since 20 vears
- Owner and founder of GMC, Global medical communication company based in USA and Mumbai www.globalmedicalcommunications-mc.com providing services: medical writing, medical attairs, Medical education, Medical malpractice and litigation, Pharma brands. Clinical expertise and Clinical consultations as Expert with the largest firms in the industry: include GLG. Guidepoint and AlphaSights
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
